About Indivumed
Indivumed is a Healthcare company based in Hamburg (Germany) founded in 2002. It operates as a biospecimens are collected, preserved, and analyzed for oncology services. The company has 178 employees. Indivumed offers products and services including Unique Database, AI Tools, and Cellular Models. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Biorepository. Its legal entity is Indivumed GmbH. Its competitors include GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain and 2 more; 6 of its 7 listed competitors have raised funding.
Company details
Indivumed was founded in 2002 in Hamburg, Germany, as an integrated oncology company. Biospecimens are collected and preserved rapidly for clinical trials, maintaining molecular patterns akin to those in the human body. Tumor tissue specimens and related molecular analytical services are provided, alongside drug and biomarker development including immunohistochemistry, phosphoprotein profiling, drug profiling, capture microdissection, and genomics services.
- Headquarters Hamburg, Germany
- Employees 178
- SectorsHealthcare
- Email••••••••
- Website indivumed.com
- Social LinkedIn
- Legal Name Indivumed Gmbh
- Latest Funding Round$47.97M (USD), Debt – Conventional
Jan 2018
- InvestorsEuropean Investment Bank
& 1 more
- Employee Count178
Products & Services of Indivumed
Indivumed offers a comprehensive portfolio of products and services, including Unique Database, AI Tools, and Cellular Models.
Comprehensive database of tumor samples for cancer research and discovery.
Biomathematical tools for target validation in oncology development.
Patient-derived models for validating cancer therapy targets.
Funding Insights of Indivumed
- Total Rounds 2
- Last Round Debt – Conventional — $47.97M
- Investors Count 2
All 2 funding rounds of Indivumed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | $47.97M | Debt – Conventional | – | – | |
| Nov 2009 | – | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Indivumed
Indivumed has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank and National Cancer Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Finance and advisory services for infrastructure projects are provided. | 1958 | eib.org | Luxembourg, Luxembourg | |
Cancer research is conducted and supported by the institute. | – | cancer.gov | Bethesda, United States |
Investor details for Indivumed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Indivumed
25 people are tracked at Indivumed (12 in leadership, 13 in team); the tracked headcount is 178.
| Name | Role | Group |
|---|---|---|
Hartmut Juhl | Founder & CEO | Leadership |
Nils Schumacher | Chief Legal Officer | Leadership |
Susanne Arbogast | Chief Medical Officer | Leadership |
Nils John Schumacher | Chief Operating Officer | Leadership |
John Marshall | Oncology Chief Medical Officer | Leadership |
Rene Steen | Vice President IT | Leadership |
Dr. Jasmin von Erichsen | Head Of Pathology | Leadership |
Nina Gabelia | Vice President Network Operations | Leadership |
Angie Reichard | Executive Vice President Of Finance | Leadership |
Kristin Maack | Vice President Marketing & Corporate Communications | Leadership |
Giorgio Modesti | Director Of Operations, South Europe | Leadership |
Anna Yabluchanska | Director Of Clinical Data Management, USA | Leadership |
Gudrun Niewel | SVP, Finance | Team |
Friederike Seemann | Clinical Data Specialist | Team |
Faisal Ejaz | Full Stack Software Developer | Team |
Anja Giese | Scientist | Team |
Sethuramalingam Duraisamy | Full Stack Engineer | Team |
Janina Froemming | Senior Marketing And Corporate Communications Manager | Team |
Sabine Meinecke | Manager Human Resources Recruiting | Team |
Dennis Gödecke | IT Administrator | Team |
5 more people are available in the full profile.
Complete people profiles for Indivumed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Indivumed
3 dated milestones of Indivumed across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Indivumed is founded.
- Funding First funding round.
- Funding Latest funding round, Debt – Conventional, of $48.0M.
Competitors of Indivumed
Indivumed has 7 listed competitors in our database, 6 of them funded. They include GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genvault.com | 2000 | Carlsbad, United States | $47.8M | – | Biosamples are stabilized, transported, stored, and retrieved by GenVault. | |
| ispecimen.com | 2009 | Lexington, United States | $11.86M | 75 | Provider of a biorepository of human clinical specimens | |
| precisionmed.com | 1996 | San Diego, United States | – | – | Human biological materials for research are supplied via a biorepository. | |
| cryoniss.com | 2018 | Macclesfield, United Kingdom | $683,055 | 9 | Provider of biobanking services for life sciences industries | |
| aminochain.io | 2022 | New York, United States | $7.07M | – | A blockchain-based platform for tokenizing and incentivizing stem cell donations | |
| viacellinc.com | 1994 | Cambridge, United States | $63M | – | Provider of services for collecting and preserving umbilical cord blood stem cells | |
| biostorage.com | 2002 | Indianapolis, United States | $8.77M | – | Provides bio repository services |
Detailed competitors of Indivumed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Indivumed
The website of Indivumed (indivumed.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 315.2% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Indivumed (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Indivumed
Complete news archive for Indivumed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indivumed
Indivumed was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Indivumed is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Indivumed has 178 employees.
Indivumed was founded in 2002 in Hamburg, Germany, as an integrated oncology company. Biospecimens are collected and preserved rapidly for clinical trials, maintaining molecular patterns akin to those in the human body. Tumor tissue specimens and related molecular analytical services are provided, alongside drug and biomarker development including immunohistochemistry, phosphoprotein profiling, drug profiling, capture microdissection, and genomics services.
Indivumed's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Indivumed offers Unique Database, AI Tools, and Cellular Models.
Indivumed has 2 investors. Key investors include European Investment Bank, and National Cancer Institute.
Indivumed operates through Indivumed Gmbh.